Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Kathleen M MooreJohn K ChanAngeles Alvarez SecordManish R PatelTimothy CallahanWei GuoZhi-Yi Zhang

Published in: Cancer chemotherapy and pharmacology (2019)

Niraparib administration at the recommended daily dose of 300 mg for EOC is not associated with clinically relevant alteration of ECGs, including QTc prolongation.

Keyphrases

papillary thyroid
squamous cell
left ventricular
drug induced
heart failure
lymph node metastasis
childhood cancer
squamous cell carcinoma
young adults